Business

T2 Biosystems, Inc. (TTOO) Shares Surge on Record Sale of Sepsis-Driven T2Dx® Instruments

Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) skyrocketed 42.39% to $0.13 on Tuesday. This surge in share value follows a significant announcement by the company regarding the second-largest sale of sepsis-driven T2Dx® Instruments in its history. The breakthrough sale was …

T2 Biosystems, Inc. (TTOO) Shares Surge on Record Sale of Sepsis-Driven T2Dx® Instruments Read More »

Eterna Therapeutics Inc. (ERNA) Stock Soars Following Appointment of Megan Yung as Chief Strategy Officer

Eterna Therapeutics Inc. (NASDAQ: ERNA) has recently named Megan Yung as their new Chief Strategy Officer and General Counsel. This appointment has led to a significant boost in the company’s stock, with shares rising by an impressive 21.49% on May …

Eterna Therapeutics Inc. (ERNA) Stock Soars Following Appointment of Megan Yung as Chief Strategy Officer Read More »

Oncolytics Biotech Inc. (ONCY) Stock Plunges Despite Positive Results from Phase 2 Breast Cancer Trial

Promising findings from the BRACELET-1 trial fail to uplift investor confidence On May 26th, Oncolytics Biotech Inc. (NASDAQ: ONCY) experienced a significant drop of -18.98% in its stock value, despite the company’s encouraging announcement regarding the positive results from the …

Oncolytics Biotech Inc. (ONCY) Stock Plunges Despite Positive Results from Phase 2 Breast Cancer Trial Read More »

Stock Plunge

Adamis Pharmaceuticals Corporation (ADMP) Shares Tumble Following Merger with DMK Pharmaceuticals

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) experienced a significant drop of 17.20% in its share price after revealing the completion of its merger with DMK Pharmaceuticals. The newly formed company aims to enhance sales of Adamis’ existing commercial products while advancing …

Adamis Pharmaceuticals Corporation (ADMP) Shares Tumble Following Merger with DMK Pharmaceuticals Read More »

Elon Musk Set to Visit China for First Time in Three Years, Aims to Strengthen Tesla’s Position in Key Market

Tesla CEO to Meet Senior Chinese Officials and Inspect Shanghai Plant Amidst Intensifying Competition and Capacity Challenges Tesla’s Chief Executive Officer (CEO), Elon Musk, is scheduled to make his first visit to China in three years, according to sources familiar …

Elon Musk Set to Visit China for First Time in Three Years, Aims to Strengthen Tesla’s Position in Key Market Read More »